Literature DB >> 7917198

Otoplasty using the postauricular skin flap technique.

T Romo1, A P Sclafani, A L Shapiro.   

Abstract

OBJECTIVE: To evaluate the efficacy of the postauricular skin flap technique in otoplasty.
DESIGN: We conducted a case series study of 25 patients who underwent bilateral otoplasty for prominent ears over a 4-year period. Follow-up ranged from 6 months to 4 years.
SETTING: Academic tertiary care referral center. PATIENTS: Twenty-five patients with congenitally prominent bilateral ears, aged 5 to 38 years of age. INTERVENTION: Cartilage-sparing otoplasties were performed with access using the postauricular skin flap technique. The specifics of cartilage correction were determined by the surgeon based on the patients' anatomic deformity. OUTCOME MEASURE: Clinically noted aesthetic results, complications, and patient satisfaction.
RESULTS: No complications, such as hypertrophic scarring, keloid formation, scar migration, ear deformity, or obliteration of the postauricular sulcus, were noted. Patient satisfaction with the procedure was generally high.
CONCLUSION: We conclude that the postauricular skin flap approach to otoplasty is safe, provides excellent exposure, is amenable to most cartilage surgical techniques, and is a valuable addition to otoplasty techniques.

Entities:  

Mesh:

Year:  1994        PMID: 7917198     DOI: 10.1001/archotol.1994.01880340086015

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  2 in total

1.  Clinical results and health-related quality of life in otoplasty patients using cartilage resection and suturing methods.

Authors:  Yuksel Toplu; Emrah Sapmaz; Cemal Firat; Sibel Altunisik Toplu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-07       Impact factor: 2.503

2.  Comparison of the result of consolidative technique otoplasty and incisionless otoplasty in the repairs of prominent ears.

Authors:  Metin Temel; Ş Şamil Kahraman; Özge Berber; Cengiz Çevik; Ertap Akoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-25       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.